Consider booking an AgeWell visit, where a Midi clinician can help you explore longevity interventions that actually have the evidence to back them upfrom hormone therapy and metabolic health to sleep, strength training, and beyond, complete with lab testing and advanced screening
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Frequently asked questions What is BPC-157 5 MG and what purity is it supplied at
Only increase if lower doses plateau and you tolerate well
FDA Category 2 peptides updates
